ABSTRACT
This article reports on the presentation, diagnosis, management, and treatment outcomes of lesions of the endolymphatic sac in patients treated at a tertiary neurotology referral center. It summarizes survival results in the largest series groups and presents a new diagnostic entity of pseudotumor of the endolymphatic sac. The study includes retrospective review of all patients diagnosed with lesions of the endolymphatic sac within our practice between 1994 and 2005 as well as review of the literature. The primary outcome measure was survival, and the secondary outcome measure was disease-free survival following definitive resection. Postoperative complications were assessed. Survival characteristics of the largest reported case series groups were reviewed. Five cases of endolymphatic sac lesions were identified. Of these, three were true endolymphatic sac tumors and two were inflammatory pseudotumors of the endolymphatic sac. All three of the endolymphatic sac tumors patients survived (100%), and two of the three had disease-free survival (67%). Two of three patients maintained persistent facial paresis postoperatively. Both patients with benign pseudotumors survived (100%). Our study concluded that endolymphatic sac tumors are rare neoplasms of the temporal bone that, although locally aggressive and invasive, have excellent prognosis for survival with complete resection. We report a new entity of pseudotumor of the endolymphatic sac that mimics true sac tumors in every respect on presentation but which is non-neoplastic in origin.
KEYWORDS
Endolymphatic sac tumor - hydrops - papillary adenoma - pseudotumor - von Hippel-Lindau disease
REFERENCES
-
1
Hassard A D, Boudreau S F, Cron C C.
Adenoma of the endolymphatic sac.
J Otolaryngol.
1984;
13
213-216
-
2
Heffner D K.
Low-grade adenocarcinoma of probable endolymphatic sac origin: a clinicopathologic study of 20 cases.
Cancer.
1989;
64
2292-2302
-
3 Stanley J, Pickett B. Endolymphatic sac tumors. In: Jackler RK Tumors of the Ear and Temporal Bone. Philadelphia; Lippincott Williams and Wilkins 2000: 156
-
4
Lo W W, Applegate L J, Carberry J N et al..
Endolymphatic sac tumors: radiologic appearance.
Radiology.
1993;
189
199-204
-
5
Megerian C A, McKenna M J, Nuss R C et al..
Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease.
Laryngoscope.
1995;
105
801-808
-
6
Benecke Jr J E, Noel F L, Carberry J N, House J W, Patterson M.
Adenomatous tumors of the middle ear and mastoid.
Am J Otol.
1990;
11
20-26
-
7
Feghali J G, Levin R J, Llena J, Bradley M K, Kantrowitz A B.
Aggressive papillary tumors of the endolymphatic sac: clinical and tissue culture characteristics.
Am J Otol.
1995;
16
778-782
-
8
Hansen M R, Luxford W M.
Surgical outcomes in patients with endolymphatic sac tumors.
Laryngoscope.
2004;
114
1470-1474
-
9
Rodrigues S, Fagan P, Turner J.
Endolymphatic sac tumors: a review of the St. Vincent's hospital experience.
Otol Neurotol.
2004;
25
599-603
-
10
Kim H J, Butman J A, Brewer C et al..
Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment.
J Neurosurg.
2005;
102
503-512
-
11
Megerian C A, Haynes D S, Poe D S, Choo D I, Keriakas T J, Glasscock III M E.
Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome.
Otol Neurotol.
2002;
23
378-387
-
12
Kempermann G, Neumann H P, Volk B.
Endolymphatic sac tumours.
Histopathology.
1998;
33
2-10
-
13
Roche P H, Dufour H, Figarella-Branger D, Pellet W.
Endolymphatic sac tumors: report of three cases.
Neurosurgery.
1998;
42
927-932
-
14
Forrest A W, Turner J J, Fagan P A.
Aggressive papillary middle ear tumour.
J Laryngol Otol.
1991;
105
950-953
-
15
Megerian C A, Pilch B Z, Bhan A K, McKenna M J.
Differential expression of transthyretin in papillary tumors of the endolymphatic sac and choroid plexus.
Laryngoscope.
1997;
107
216-221
-
16
Lonser R R, Kim H J, Butman J A, Vortmeyer A O, Choo D I, Oldfield E H.
Tumors of the endolymphatic sac in von Hippel-Lindau disease.
N Engl J Med.
2004;
350
2481-2486
-
17
Noujaim S E, Pattekar M A, Cacciarelli A, Sanders W P, Wang A M.
Paraganglioma of the temporal bone: role of magnetic resonance imaging versus computed tomography.
Top Magn Reson Imaging.
2000;
11
108-122
-
18
Patel N P, Wiggins III R H, Shelton C.
The radiologic diagnosis of endolymphatic sac tumors.
Laryngoscope.
2006;
116
40-46
-
19
Shin J H, Lee H K, Jeong A K, Park S H, Choi C G, Suh D C.
Choroid plexus papilloma in the posterior cranial fossa: MR, CT, and angiographic findings.
Clin Imaging.
2001;
25
154-162
-
20
Mukherji S K, Albernaz V S, Lo W W et al..
Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients.
Radiology.
1997;
202
801-808
-
21
Wagle V, Melanson D, Ethier R, Bertrand G, Villemure J G.
Choroid plexus papilloma: magnetic resonance, computed tomography, and angiographic observations.
Surg Neurol.
1987;
27
466-468
-
22
Gadre A K, Fayad J N, O'Leary M J, Zakhary R, Linthicum Jr F H.
Arterial supply of the human endolymphatic duct and sac.
Otolaryngol Head Neck Surg.
1993;
108
141-148
-
23
Neumann H P, Wiestler O D.
Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus.
Lancet.
1991;
337
1052-1054
-
24
Bambakidis N C, Megerian C A, Ratcheson R A.
Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status.
Otol Neurotol.
2004;
25
773-781
-
25
Latif F, Tory K, Gnarra J et al..
Identification of the von Hippel-Lindau disease tumor suppressor gene.
Science.
1993;
260
1317-1320
-
26
Kim W Y, Kaelin W G.
Role of VHL gene mutation in human cancer.
J Clin Oncol.
2004;
22
4991-5004
-
27
Vortmeyer A O, Choo D, Pack S D, Oldfield E, von Zhuang Z.
Hippel-Lindau disease gene alterations associated with endolymphatic sac tumor.
J Natl Cancer Inst.
1997;
89
970-972
-
28
Manski T J, Heffner D K, Glenn G M et al..
Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel-Lindau disease.
JAMA.
1997;
277
1461-1466
-
29
Vortmeyer A O, Huang S C, Koch C A et al..
Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
Cancer Res.
2000;
60
5963-5965
-
30
Chen F, Kishida T, Yao M et al..
Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
Hum Mutat.
1995;
5
66-75
-
31
Ferreira M A, Feiz-Erfan I, Zabramski J M, Spetzler R F, Coons S W, Preul M C.
Endolymphatic sac tumor: unique features of two cases and review of the literature.
Acta Neurochir (Wien).
2002;
144
1047-1053
-
32
Bambakidis N C, Rodrigue T, Megerian C A, Ratcheson R A.
Endolymphatic sac tumor metastatic to the spine: case report.
J Neurosurg Spine.
2005;
3
68-70
-
33
Hashimoto M, Yokota A, Urasaki E, Imada H, Yamamoto H.
Surgical treatment of endolymphatic sac tumor with adjunctive stereotactic radiation therapy: case report.
Neurol Med Chir (Tokyo).
2004;
44
595-599
-
34
Zechner G, Altmann F.
Histological studies on the human endolymphatic duct and sac.
Pract Otorhinolaryngol (Basel).
1969;
31
65-83
-
35
Ikeda M, Sando I.
Endolymphatic duct and sac in patients with Meniere's disease: a temporal bone histopathological study.
Ann Otol Rhinol Laryngol.
1984;
93
540-546
-
36
Schindler R A.
The ultrastructure of the endolymphatic sac in man.
Laryngoscope.
1980;
90
1-39
-
37
Schindler R A.
Histopathology of the human endolymphatic sac.
Am J Otol.
1981;
3
139-143
-
38
Fitzgerald D C, Mark A S.
Endolymphatic duct/sac enhancement on gadolinium magnetic resonance imaging of the inner ear: preliminary observations and case reports.
Am J Otol.
1996;
17
603-606
Rodney C DiazM.D.
Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of California Davis Medical Center
2521 Stockton Boulevard, Suite 7200, Sacramento, CA 95817
Email: rcdiaz@ucdavis.edu
